Psychopharmacology Practice Questions and Answers

Psychopharmacology is one of the most essential areas in psychiatry, psychology, nursing, and mental health training. It bridges the science of brain chemistry with the clinical art of using medications to treat mental illness. If you are preparing for a psychopharmacology exam or simply want to strengthen your knowledge of psychiatric medications, mechanisms of action, and clinical guidelines, this Psychopharmacology Practice Exam provides the complete preparation package you need. With hundreds of carefully designed multiple-choice questions and in-depth explanations, this exam bank equips you to master difficult concepts and apply them in real clinical scenarios.

What is Psychopharmacology?

Psychopharmacology is the scientific study of how drugs affect the mind, mood, cognition, and behavior. It examines the relationship between the brain’s neurotransmitter systems and medications such as antidepressants, antipsychotics, mood stabilizers, and anxiolytics. This discipline is not just about memorizing drug names; it is about understanding how psychiatric medications work, their side effects, and how to use them safely in different patient populations.

Psychopharmacology integrates knowledge from neuroscience, psychiatry, pharmacology, and psychology, making it a critical area for mental health professionals. Students preparing for exams in this field must know both the theoretical principles and the practical aspects of prescribing and monitoring medications.

Types of Psychopharmacology

Psychopharmacology is a broad field with several sub-areas, each focusing on a different perspective of drug action:

• Clinical Psychopharmacology – The application of psychotropic medications in treating psychiatric disorders. This is the most practical type, used by psychiatrists, nurse practitioners, and psychiatric pharmacists.
• Neuropsychopharmacology – Investigates how drugs affect the brain’s neural circuits and neurotransmitter systems, linking molecular action to behavior and cognition.
• Behavioral Psychopharmacology – Studies how medications influence learning, reward, reinforcement, and addiction.
• Experimental Psychopharmacology – Conducts laboratory and preclinical research, often using animal models, to test new drugs or understand drug mechanisms.
• Pharmacogenetics in Psychopharmacology – A growing area in 2025, exploring how genetic variations affect individual responses to psychiatric medications.

Understanding these types helps learners approach psychopharmacology not just as a memorization task but as a multi-dimensional science.

About This Psychopharmacology Practice Exam

The Psychopharmacology Practice Exam is designed to mirror real test conditions while also serving as an advanced learning tool. The exam includes over 1000+ multiple-choice questions with detailed explanations based on current 2025 guidelines and recent FDA approvals. Every question is carefully crafted to cover high-yield topics, including:

• Mechanisms of action for antidepressants, antipsychotics, anxiolytics, and mood stabilizers
• Clinical indications, contraindications, and black box warnings
• Pharmacokinetics and drug–drug interactions (e.g., CYP450 metabolism)
• Side effect profiles, from metabolic syndrome to serotonin syndrome
• Emerging treatments like esketamine, MDMA-assisted therapy, and digital psychiatry tools
• Precision medicine in psychopharmacology, including pharmacogenomics and microbiome research

With in-depth rationales, this exam goes beyond simple answers, ensuring you understand why a drug is used, how it works, and what risks it carries.

Topics Covered

The practice exam spans all the critical areas you need to know:

• Antidepressants – SSRIs, SNRIs, MAOIs, TCAs, and novel agents like vortioxetine and agomelatine
• Antipsychotics – Typical and atypical antipsychotics, clozapine monitoring, long-acting injectables, and new approvals such as brexpiprazole for Alzheimer’s agitation
• Mood Stabilizers – Lithium, valproate, lamotrigine, carbamazepine, and their pregnancy and toxicity considerations
• Anxiolytics and Hypnotics – Benzodiazepines, buspirone, hydroxyzine, and insomnia treatments
• Emerging Therapies – Esketamine for TRD, zuranolone for postpartum depression, psychedelic-assisted psychotherapy (MDMA, psilocybin)
• Side Effect Management – Neuroleptic malignant syndrome, serotonin syndrome, tardive dyskinesia, metabolic syndrome
• Professional Applications – Digital adherence tools, wearable monitoring, and pharmacogenomic testing

This wide coverage ensures that you are fully prepared for both traditional board exams and cutting-edge developments in psychiatry.

Who Can Take This Psychopharmacology Practice Exam?

The Psychopharmacology Practice Exam is designed for a broad audience, including:

• Medical students and psychiatry residents preparing for clinical rotations, shelf exams, or board certification
• Psychiatric nurse practitioners (PMHNPs) and physician assistants expanding their prescribing knowledge
• Psychologists in states with prescriptive authority or completing a Master’s in Clinical Psychopharmacology (MSCP)
• Pharmacy students and psychiatric pharmacists (PharmDs) specializing in psychotropic medication management
• Nursing students preparing for NCLEX or advanced psychiatric nursing exams
• Mental health professionals who want to update their knowledge with 2025 guideline changes

Whether you are a student, a clinician, or an academic researcher, this exam is tailored to meet your needs.

Benefits of Taking This Psychopharmacology Practice Exam

1. Comprehensive Preparation – With over 1000+ practice questions, you gain exposure to every important psychopharmacology topic.
2. Updated for 2026 – Includes the latest FDA approvals, guideline changes, and precision medicine trends.
3. Detailed Explanations – Learn not just the correct answer, but the reasoning behind it.
4. Career Advantage – Build confidence for board exams, licensure, or job interviews in psychiatry and mental health.
5. Practical Application – Strengthen your ability to manage patients, monitor side effects, and personalize treatment plans.
6. Flexible Learning – Use it for self-study, classroom preparation, or continuing education.

By completing this exam, you will have the confidence to handle both test questions and real-world clinical challenges.

How to Study Psychopharmacology Effectively

Studying psychopharmacology can feel overwhelming because of the vast number of drugs, mechanisms, and interactions. Here are proven study strategies:

• Break content into systems – Group antidepressants, antipsychotics, mood stabilizers, and anxiolytics separately.
• Use practice questions – Testing yourself is the best way to reinforce memory and clinical reasoning.
• Focus on mechanisms and patterns – Understand how SSRIs differ from SNRIs, or why clozapine requires unique monitoring.
• Integrate clinical cases – Apply knowledge to scenarios involving side effects, pregnancy, or comorbid conditions.
• Review emerging therapies – Stay current with esketamine, brexpiprazole, and psychedelic research.
• Use spaced repetition – Regularly revisit questions to reinforce long-term retention.

This exam is structured to help you apply all of these methods, making your study efficient and exam-ready.

Mastering psychopharmacology is essential for anyone in psychiatry, nursing, pharmacy, or psychology. With its blend of theory, clinical application, and updated research, this Psychopharmacology Practice Exam offers a unique opportunity to test your knowledge, strengthen your confidence, and excel in your exams. Whether you are preparing for a classroom test, a licensing board, or your psychopharmacology final exam, this resource is designed to guide you toward success. Whether your goal is board certification, professional advancement, or simply becoming a more effective clinician, this exam is your trusted companion on the path to excellence.

Why Students Trust This Practice Exam

Psychopharmacology is a subject where understanding why a medication is prescribed is just as important as knowing what it treats. Students preparing for university examinations, psychiatric nursing courses, psychology programs, pharmacy education, or professional certification exams often struggle with the large number of medications, mechanisms of action, adverse effects, contraindications, and clinical applications they must master. This practice exam is designed to make that learning process more manageable through realistic, knowledge-based questions that encourage deeper understanding.

Rather than relying solely on memorization, the practice questions are structured to reinforce clinical reasoning and strengthen your ability to recognize medication patterns, interpret patient scenarios, and distinguish between similar drug classes. Detailed answer explanations provide the reasoning behind each correct response, helping you connect pharmacology concepts with practical mental health care.

Many learners also appreciate the flexibility of practicing at their own pace. You can identify weaker topics, review explanations, and revisit difficult questions as your understanding improves. This process promotes long-term retention and helps build confidence before classroom exams, certification tests, or professional assessments.

Whether you are studying antidepressants, antipsychotics, mood stabilizers, anxiolytics, stimulants, or emerging psychiatric therapies, this practice exam provides a structured way to assess your progress and strengthen your understanding of modern psychopharmacology.

How the Questions Are Developed

The questions in this psychopharmacology practice exam are written to evaluate practical knowledge of psychiatric medications and their clinical use. Instead of focusing only on isolated drug facts, many questions require you to apply pharmacological principles, interpret clinical information, and make informed decisions based on patient presentations similar to those encountered in academic and professional examinations.

Question topics are selected to cover the major areas of psychopharmacology, including neurotransmitter systems, mechanisms of action, therapeutic indications, adverse effects, drug interactions, monitoring requirements, contraindications, and medication safety. Additional emphasis is placed on understanding the differences between medication classes and recognizing situations where one treatment approach may be more appropriate than another.

Every question is accompanied by a detailed explanation that reinforces key learning objectives. These explanations clarify important concepts, explain why the correct answer is appropriate, and discuss why alternative options are less suitable. Reviewing these rationales helps transform practice sessions into meaningful learning opportunities instead of simple self-testing.

This practice exam is intended to complement textbooks, classroom instruction, clinical training, and other study resources by providing comprehensive question-based practice that supports both exam preparation and a stronger understanding of evidence-based psychopharmacology.

Psychopharmacology Sample Questions and Answers

A patient discontinued fluoxetine after inadequate symptom control and is requesting to begin phenelzine immediately. What is the safest recommendation?

A. Begin phenelzine the next day

B. Wait at least 5 weeks before starting phenelzine

C. Start both medications together for one week

D. Replace fluoxetine with venlafaxine first

Correct Answer: B. Wait at least 5 weeks before starting phenelzine

Explanation:

Fluoxetine has a much longer half-life than most SSRIs because its active metabolite, norfluoxetine, remains in the body for several weeks. Starting an MAOI too soon can dramatically increase serotonin activity and lead to serotonin syndrome, a potentially life-threatening condition characterized by agitation, hyperreflexia, autonomic instability, and hyperthermia. Current psychopharmacology guidelines recommend a washout period of at least five weeks after stopping fluoxetine before initiating phenelzine or another MAOI. This recommendation is unique to fluoxetine; shorter-acting SSRIs generally require a two-week washout before MAOI therapy.

A patient stabilized on paroxetine begins taking a medication that strongly inhibits CYP2D6. Which outcome is most likely?

A. Lower paroxetine concentrations

B. Increased paroxetine concentrations and adverse effects

C. Immediate serotonin depletion

D. Faster renal elimination

Correct Answer: B. Increased paroxetine concentrations and adverse effects

Explanation:

Many antidepressants undergo metabolism through the cytochrome P450 (CYP450) enzyme system. Paroxetine is primarily metabolized through CYP2D6, so adding a potent CYP2D6 inhibitor can significantly increase plasma drug levels. Higher concentrations raise the risk of nausea, sedation, sexual dysfunction, and serotonin toxicity. Understanding CYP450 metabolism helps clinicians anticipate clinically important drug interactions before symptoms occur. Pharmacists and psychiatric providers routinely evaluate enzyme inhibitors and inducers when prescribing antidepressants, antipsychotics, or mood stabilizers. Medication reconciliation remains an essential component of safe psychopharmacology practice.

A patient receiving lithium develops coarse tremors, slurred speech, confusion, and difficulty walking after becoming dehydrated from viral gastroenteritis. What should be done first?

A. Increase the lithium dose

B. Hold lithium and obtain an urgent serum lithium level

C. Continue treatment and reassess next month

D. Switch immediately to olanzapine

Correct Answer: B. Hold lithium and obtain an urgent serum lithium level

Explanation:

Lithium has a narrow therapeutic index, making toxicity a significant clinical concern. Dehydration, sodium depletion, kidney dysfunction, NSAIDs, ACE inhibitors, and certain diuretics can reduce lithium clearance and elevate serum concentrations. Neurologic findings such as coarse tremor, ataxia, confusion, dysarthria, and altered consciousness suggest toxicity requiring prompt evaluation. Immediate management includes holding lithium, checking serum lithium levels, assessing renal function, and correcting fluid and electrolyte abnormalities. Severe toxicity may require hospitalization or hemodialysis. Patient education about hydration remains one of the most effective preventive strategies.

A patient with treatment-resistant schizophrenia is responding well to clozapine. Which laboratory value requires routine monitoring throughout therapy?

A. Serum calcium

B. Absolute neutrophil count

C. Thyroid-stimulating hormone

D. Vitamin D level

Correct Answer: B. Absolute neutrophil count

Explanation:

Clozapine remains the most effective antipsychotic for treatment-resistant schizophrenia but carries a risk of severe neutropenia and agranulocytosis. Because of this potentially life-threatening adverse effect, routine monitoring of the absolute neutrophil count (ANC) is mandatory. Patients are enrolled in monitoring programs to ensure laboratory testing occurs at recommended intervals. Clozapine also requires monitoring for myocarditis, seizures, constipation, hypersalivation, metabolic syndrome, and significant weight gain. Despite these risks, clozapine substantially reduces suicide risk in appropriate patients and remains an essential medication for refractory psychotic illness.

A patient is brought to the emergency department after intentionally ingesting a large amount of amitriptyline. Which electrocardiogram finding is particularly concerning?

A. Shortened PR interval

B. Widened QRS complex

C. Isolated sinus bradycardia

D. Normal QT interval

Correct Answer: B. Widened QRS complex

Explanation:

Tricyclic antidepressant (TCA) overdose remains a medical emergency because these medications block fast sodium channels in the myocardium. Amitriptyline toxicity commonly produces QRS widening, ventricular arrhythmias, hypotension, seizures, and altered mental status. A widened QRS complex is associated with increased risk of life-threatening cardiac complications. Intravenous sodium bicarbonate is the primary treatment for significant cardiac toxicity because it narrows the QRS complex and improves myocardial conduction. Continuous cardiac monitoring and early supportive management are essential until the patient is clinically stable.

A 37-year-old woman with major depressive disorder reports severe fatigue, low energy, and poor concentration. She has no history of hypertension or seizures. Which medication is most likely to improve both mood and energy?

A. Fluvoxamine

B. Duloxetine

C. Clomipramine

D. Phenelzine

Correct Answer: B. Duloxetine

Explanation:

Duloxetine is an SNRI that inhibits both serotonin and norepinephrine reuptake. Compared with SSRIs, SNRIs often provide greater improvement in symptoms such as fatigue, reduced motivation, and impaired concentration because norepinephrine contributes to alertness and energy regulation. Duloxetine is also beneficial for neuropathic pain and fibromyalgia, making it useful in patients with depression and chronic pain. Blood pressure should be monitored during treatment because norepinephrine enhancement may increase blood pressure in susceptible individuals. Treatment selection should always consider comorbid illnesses, medication interactions, and individual patient response.

A patient taking sertraline says, “I feel completely better and want to stop my medication today.”

What is the best response?

A. Stop immediately because symptoms resolved.

B. Continue therapy for an appropriate maintenance period before gradual tapering.

C. Switch directly to an MAOI.

D. Take sertraline every other week.

Correct Answer: B. Continue therapy for an appropriate maintenance period before gradual tapering.

Explanation:

Improvement in depressive symptoms does not mean treatment should stop immediately. Clinical guidelines recommend continuing antidepressant therapy after remission to reduce relapse risk. Abrupt discontinuation may also produce withdrawal symptoms, especially with short half-life antidepressants. A gradual taper allows the brain to adapt while reducing discontinuation symptoms such as dizziness, insomnia, irritability, and sensory disturbances. Treatment duration depends on factors including previous depressive episodes, symptom severity, suicide risk, and underlying psychiatric history. Shared decision-making improves long-term adherence and outcomes.

Which genetic test panel is increasingly used to guide antidepressant prescribing in 2025?

A) CYP450 pharmacogenomic panels
B) EEG biomarker test
C) PET brain imaging
D) Microbiome sequencing
Answer: A) CYP450 pharmacogenomic panels

Explanation: Pharmacogenomic testing (CYP2D6, CYP2C19, SLC6A4) is used more widely in 2025 to personalize antidepressant selection, minimizing side effects and treatment failures.

A patient has failed four antidepressants despite good adherence. The psychiatrist orders pharmacogenomic testing before selecting another medication. What is the primary purpose of this testing?

A. Diagnose bipolar disorder

B. Predict how genetic variants may influence medication metabolism

C. Measure current serotonin levels

D. Determine lithium concentrations

Correct Answer: B. Predict how genetic variants may influence medication metabolism

Explanation

Pharmacogenomic testing evaluates inherited genetic variants affecting drug-metabolizing enzymes such as CYP2D6 and CYP2C19. Results may explain why some patients experience unexpected adverse effects or poor therapeutic response at standard doses. Although pharmacogenomics does not predict every aspect of antidepressant response, it can help clinicians choose medications requiring fewer dose adjustments. Testing complements—but never replaces—clinical assessment, treatment history, medication adherence, and patient preferences. Personalized medicine continues to expand its role in psychopharmacology as evidence supporting genotype-guided prescribing grows.

Which neurotransmitter is primarily targeted by SSRIs?

A) Dopamine
B) Serotonin
C) GABA
D) Norepinephrine
Answer: B) Serotonin

Explanation: SSRIs selectively block the reuptake of serotonin, increasing its availability in the synaptic cleft. This helps alleviate depressive symptoms by enhancing serotonergic signaling, which regulates mood, appetite, and sleep.

Which drug remains the first-line standard for reducing suicidality in bipolar disorder?

A) Lamotrigine
B) Valproate
C) Lithium
D) Brexpiprazole
Answer: C) Lithium

Explanation: Even in 2025, lithium uniquely reduces suicide risk, making it indispensable despite newer alternatives.

Which antidepressant received FDA approval in 2023 for postpartum depression (first oral option)?

A) Sertraline
B) Fluoxetine
C) Zuranolone
D) Brexanolone
Answer: C) Zuranolone

Explanation: Zuranolone, an oral neuroactive steroid (GABA-A modulator), was FDA-approved in 2023 for postpartum depression, offering easier use than IV brexanolone.

Benzodiazepines act mainly on which receptor subtype?

A) NMDA
B) AMPA
C) GABA-A
D) GABA-B
Answer: C) GABA-A

Explanation: Benzodiazepines enhance the effect of GABA at GABA-A receptors by increasing the frequency of chloride channel opening. This produces anxiolytic, sedative, and muscle relaxant effects, making them effective in acute anxiety and seizures.

Clozapine is reserved for which condition?

A) First-line depression
B) Bipolar maintenance
C) Treatment-resistant schizophrenia
D) ADHD
Answer: C) Treatment-resistant schizophrenia

Explanation: Clozapine is effective for patients unresponsive to other antipsychotics. It has superior efficacy in reducing suicidality but requires regular blood monitoring due to risk of agranulocytosis.

Which antidepressant has the lowest risk of sexual dysfunction?

A) Paroxetine
B) Fluoxetine
C) Bupropion
D) Sertraline
Answer: C) Bupropion

Explanation: Bupropion inhibits norepinephrine and dopamine reuptake without significant serotonergic activity. This profile reduces the incidence of sexual side effects, a common problem with SSRIs.

Lithium toxicity is most likely when combined with:

A) Antacids
B) ACE inhibitors
C) Antihistamines
D) SSRIs
Answer: B) ACE inhibitors

Explanation: ACE inhibitors reduce renal clearance of lithium, increasing serum levels and toxicity risk. Monitoring lithium levels is critical since the therapeutic window is narrow.

Which drug is most associated with tardive dyskinesia?

A) Haloperidol
B) Quetiapine
C) Clozapine
D) Risperidone
Answer: A) Haloperidol

Explanation: Typical antipsychotics like haloperidol strongly block dopamine D2 receptors. Chronic blockade can lead to upregulation and hypersensitivity, causing involuntary movements known as tardive dyskinesia.

What is the primary mechanism of action of SNRIs?

A) Increase serotonin release
B) Block dopamine reuptake
C) Inhibit serotonin and norepinephrine reuptake
D) Stimulate MAO-A
Answer: C) Inhibit serotonin and norepinephrine reuptake

Explanation: SNRIs enhance both serotonergic and noradrenergic neurotransmission, making them useful for depression, generalized anxiety disorder, and neuropathic pain.

Which drug can cause hypertensive crisis with tyramine-rich foods?

A) SSRIs
B) MAOIs
C) TCAs
D) Benzodiazepines
Answer: B) MAOIs

Explanation: MAOIs inhibit breakdown of tyramine, leading to excessive norepinephrine release. This interaction can trigger dangerous hypertensive crises, requiring strict dietary restrictions.

Which antipsychotic is most likely to cause metabolic syndrome?

A) Olanzapine
B) Haloperidol
C) Ziprasidone
D) Fluphenazine
Answer: A) Olanzapine

Explanation: Olanzapine and clozapine significantly increase risk of weight gain, hyperlipidemia, and diabetes. Metabolic monitoring is essential during long-term use.

Which neurotransmitter is central to Parkinson’s disease psychopharmacology?

A) Serotonin
B) GABA
C) Dopamine
D) Glutamate
Answer: C) Dopamine

Explanation: Dopamine deficiency in the substantia nigra underlies motor symptoms. Treatment often includes levodopa or dopamine agonists, but long-term use may cause dyskinesias and psychiatric side effects.

Buspirone is used primarily for:

A) Panic disorder
B) Schizophrenia
C) Generalized anxiety disorder
D) OCD
Answer: C) Generalized anxiety disorder

Explanation: Buspirone acts as a partial agonist at serotonin 5-HT1A receptors. Unlike benzodiazepines, it is non-sedating, non-addictive, but requires weeks for full effect.

Which antidepressant is contraindicated in patients with seizures?

A) Fluoxetine
B) Bupropion
C) Sertraline
D) Venlafaxine
Answer: B) Bupropion

Explanation: Bupropion lowers seizure threshold, making it unsuitable for individuals with epilepsy or eating disorders, where electrolyte imbalance already increases risk.

The “cheese effect” is associated with which drug class?

A) SSRIs
B) MAOIs
C) TCAs
D) SNRIs
Answer: B) MAOIs

Explanation: The cheese effect refers to hypertensive crises caused by dietary tyramine. MAOIs prevent its breakdown, leading to a sudden and dangerous rise in blood pressure.

Which SSRI is most activating and often taken in the morning?

A) Fluoxetine
B) Paroxetine
C) Sertraline
D) Escitalopram
Answer: A) Fluoxetine

Explanation: Fluoxetine has a long half-life and tends to be stimulating, improving energy. Morning dosing reduces risk of insomnia and ensures steady plasma levels.

Which drug requires regular WBC monitoring?

A) Clozapine
B) Haloperidol
C) Aripiprazole
D) Quetiapine
Answer: A) Clozapine

Explanation: Clozapine can cause agranulocytosis, a potentially fatal drop in white blood cells. Regular CBC monitoring is mandatory to ensure patient safety.

What is the primary risk of abrupt benzodiazepine withdrawal?

A) Fatigue
B) Seizures
C) Psychosis
D) Hallucinations
Answer: B) Seizures

Explanation: Sudden cessation after chronic benzodiazepine use leads to CNS hyperexcitability due to GABA downregulation. This can precipitate life-threatening withdrawal seizures.

Which antidepressant is most sedating and often used off-label for insomnia?

A) Venlafaxine
B) Trazodone
C) Bupropion
D) Fluoxetine
Answer: B) Trazodone

Explanation: Trazodone is a serotonin antagonist and reuptake inhibitor. At low doses, its antihistaminic effects dominate, making it helpful for sleep difficulties in depression.

Which medication is first-line for acute mania?

A) Lithium
B) Fluoxetine
C) Haloperidol
D) Valproate
Answer: D) Valproate

Explanation: Valproate stabilizes mood rapidly by enhancing GABA activity. It is effective in acute mania, particularly when lithium is contraindicated or requires slower titration.

Which antipsychotic has partial dopamine agonist activity?

A) Risperidone
B) Clozapine
C) Aripiprazole
D) Quetiapine
Answer: C) Aripiprazole

Explanation: Aripiprazole acts as a dopamine D2 partial agonist, balancing dopamine activity. This mechanism reduces risk of extrapyramidal symptoms and prolactin elevation.

What is the mechanism of TCAs?

A) Block serotonin transporters
B) Inhibit serotonin and norepinephrine reuptake
C) Block dopamine receptors
D) Inhibit MAO
Answer: B) Inhibit serotonin and norepinephrine reuptake

Explanation: TCAs increase serotonergic and noradrenergic neurotransmission but also block histamine and muscarinic receptors, leading to sedation, dry mouth, and cardiotoxicity in overdose.

Which mood stabilizer is teratogenic, especially causing neural tube defects?

A) Lithium
B) Valproate
C) Carbamazepine
D) Lamotrigine
Answer: B) Valproate

Explanation: Valproate carries high teratogenic risk, particularly spina bifida. Women of childbearing age require careful counseling, folate supplementation, and alternative treatments if possible.

Which drug is contraindicated with serotonergic agents due to serotonin syndrome?

A) Diazepam
B) St. John’s Wort
C) Chlorpromazine
D) Hydroxyzine
Answer: B) St. John’s Wort

Explanation: St. John’s Wort increases serotonin activity and can dangerously interact with SSRIs, SNRIs, or MAOIs, precipitating serotonin syndrome with agitation, hyperthermia, and seizures.

Which drug can cause gingival hyperplasia as a side effect?

A) Phenytoin
B) Valproate
C) Lithium
D) Lamotrigine
Answer: A) Phenytoin

Explanation: Phenytoin, an anticonvulsant sometimes used in mood stabilization, promotes abnormal gum overgrowth. Good oral hygiene and dental care help mitigate this effect.

Which SSRI has the longest half-life?

A) Paroxetine
B) Sertraline
C) Fluoxetine
D) Escitalopram
Answer: C) Fluoxetine

Explanation: Fluoxetine’s long half-life and active metabolite (norfluoxetine) allow for steady plasma levels and reduced withdrawal risk, but it requires a washout before switching to MAOIs.

Lamotrigine is most effective for which phase of bipolar disorder?

A) Acute mania
B) Maintenance, preventing depression
C) Rapid cycling
D) Mixed episodes
Answer: B) Maintenance, preventing depression

Explanation: Lamotrigine is especially effective at preventing depressive relapses in bipolar disorder, though it is less effective for mania. Slow titration reduces risk of Stevens-Johnson syndrome.

Which antipsychotic is most associated with QT prolongation?

A) Ziprasidone
B) Olanzapine
C) Aripiprazole
D) Risperidone
Answer: A) Ziprasidone

Explanation: Ziprasidone can significantly prolong QT interval, increasing risk of torsades de pointes. Baseline ECG and caution in cardiac patients are advised.

Which neurotransmitter imbalance is linked to OCD?

A) Low dopamine
B) Low serotonin
C) High GABA
D) High acetylcholine
Answer: B) Low serotonin

Explanation: OCD is strongly associated with serotonergic dysfunction. SSRIs are first-line treatment, as enhancing serotonin reduces intrusive thoughts and compulsive behaviors.

Which antidepressant carries the highest risk of discontinuation syndrome?

A) Paroxetine
B) Fluoxetine
C) Sertraline
D) Escitalopram
Answer: A) Paroxetine

Explanation: Paroxetine’s short half-life causes rapid onset of withdrawal symptoms like dizziness, irritability, and flu-like signs if stopped suddenly. Tapering is necessary.

What is the most dangerous TCA side effect in overdose?

A) Dry mouth
B) Constipation
C) Cardiac arrhythmia
D) Sedation
Answer: C) Cardiac arrhythmia

Explanation: TCAs block cardiac sodium channels, leading to conduction delays and arrhythmias, which are the primary cause of death in overdose. ECG monitoring is essential.

Which drug is most effective at reducing alcohol cravings?

A) Naltrexone
B) Diazepam
C) Lithium
D) Clozapine
Answer: A) Naltrexone

Explanation: Naltrexone blocks opioid receptors, reducing the rewarding effects of alcohol and curbing cravings. It is effective in relapse prevention for alcohol use disorder.

A patient develops severe muscle stiffness, high fever, confusion, and autonomic instability three days after starting haloperidol.

What is the immediate priority?

A. Continue haloperidol and observe

B. Suspect neuroleptic malignant syndrome and discontinue the antipsychotic

C. Increase the medication dose

D. Begin an SSRI

Correct Answer: B. Suspect neuroleptic malignant syndrome and discontinue the antipsychotic

Explanation:

Neuroleptic Malignant Syndrome (NMS) is a medical emergency associated with dopamine-blocking medications, particularly high-potency antipsychotics such as haloperidol. Prompt discontinuation of the offending medication is the first priority, followed by supportive care, aggressive hydration, temperature control, and intensive monitoring. Laboratory findings often reveal elevated creatine kinase from muscle breakdown. Untreated NMS may progress to renal failure, respiratory compromise, disseminated intravascular coagulation, and death. Early recognition of rigidity, hyperthermia, altered mental status, and autonomic instability is essential for improving patient outcomes.

A 45-year-old man with schizophrenia has been stable on clozapine for two years. During hospitalization, he abruptly stops smoking cigarettes. Five days later, he becomes excessively sedated and complains of dizziness. Which explanation best accounts for this change?

A. Smoking increases renal clearance of clozapine.

B. Smoking induces CYP1A2, and stopping smoking can increase clozapine concentrations.

C. Nicotine blocks dopamine receptors.

D. Clozapine loses effectiveness after smoking cessation.

Correct Answer: B. Smoking induces CYP1A2, and stopping smoking can increase clozapine concentrations.

Explanation:

Tobacco smoke—not nicotine itself—contains polycyclic aromatic hydrocarbons that induce CYP1A2, the primary enzyme responsible for metabolizing clozapine. When a patient suddenly stops smoking, CYP1A2 activity decreases, causing clozapine concentrations to rise. This increase may produce sedation, dizziness, hypersalivation, confusion, or seizures if doses are not adjusted appropriately. Clinicians should ask about smoking habits whenever prescribing clozapine or olanzapine because changes in tobacco use can significantly alter drug exposure. Medication doses often require reassessment after smoking cessation or resumption.

A 30-year-old woman with bipolar I disorder discovers she is eight weeks pregnant while taking valproate. Which concern is most strongly associated with continued valproate exposure during the first trimester?

A. Increased risk of neural tube defects

B. Increased risk of cataracts

C. Permanent maternal hypertension

D. Hyperthyroidism

Correct Answer: A. Increased risk of neural tube defects

Explanation:

Valproate is one of the most teratogenic medications used in psychiatry. First-trimester exposure substantially increases the risk of neural tube defects, including spina bifida, along with congenital heart defects, craniofacial abnormalities, and impaired neurodevelopment. Women of childbearing potential should receive counseling regarding pregnancy planning and effective contraception before valproate is prescribed. When pregnancy occurs, treatment decisions require careful collaboration among psychiatry, obstetrics, and the patient to balance maternal psychiatric stability against fetal risk.